tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market
Advertisement

Crispr Therapeutics AG (CRSP) Ownership - Who Owns Crispr Therapeutics AG?

Compare
10,358 Followers

Crispr Therapeutics AG (CRSP) Ownership Overview

2.73%13.47%40.54%21.43%21.84%
40.54% Other Institutional Investors
21.43% ETFs
21.84% Public Companies and Individual Investors
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 75.43% of the company’s stock is owned by Institutional Investors, 2.73% is owned by Insiders, and 21.84% is owned by Public Companies and Individual Investors.
The ownership structure of Crispr Therapeutics AG (CRSP) stock is a mix of institutional, retail, and individual investors. Approximately 54.01% of the company’s stock is owned by Institutional Investors, 2.73% is owned by Insiders, and 21.43% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 08, 2025
xxxxxxxxxxxxx
$1140600
Jul 17, 2025
xxxxxxxxxxxxx
$51499918
Feb 28, 2025
xxxxxxxxxxxxx
$313880

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,806,892Institution11.88%607,995,744
10,182,590Institution11.20%572,872,513
3,986,732Institution4.38%224,293,542
2,146,363Institution2.36%120,754,382
2,038,763Insider2.24%114,700,806
1,654,370Institution1.82%93,074,856
1,647,885Institution1.81%92,710,010
1,606,438Institution1.77%90,378,202
1,491,000Institution1.64%83,883,660
1,334,645Institution1.47%75,087,128

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,146,363Institution2.36%120,754,382
1,647,885Institution1.81%92,710,010
1,491,000Institution1.64%83,883,660
1,334,645Institution1.47%75,087,128
957,432Institution1.05%53,865,124
925,518Institution1.02%52,069,643
862,495Institution0.95%48,523,969
689,399Institution0.76%38,785,588
351,358Institution0.39%19,767,401
288,493Institution0.32%16,230,616

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
9,420,785Institution10.36%530,013,364
2,056,979Institution2.26%115,725,639
1,729,494Institution1.90%97,301,332
1,445,908Institution1.59%80,811,798
927,867Institution1.02%52,201,797
727,790Institution0.80%40,945,465
500,060Institution0.55%28,133,376
409,674Institution0.45%22,896,680
394,323Institution0.43%22,184,612
342,104Institution0.38%19,120,193

FAQ

Who Owns Crispr Therapeutics AG (CRSP)?
According to the latest TipRanks data, approximately 40.54% of the company's stock is held by institutional investors, 2.73% is held by insiders, and 21.84% is held by retail investors.
    What percentage of Crispr Therapeutics AG (CRSP) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 40.54% of Crispr Therapeutics AG (CRSP) stock is held by institutional investors.
      What percentage of Crispr Therapeutics AG (CRSP) stock is held by retail investors?
      According to the latest TipRanks data, approximately 21.84% of Crispr Therapeutics AG (CRSP) stock is held by retail investors.
        Who owns the most shares of Crispr Therapeutics AG (CRSP)?
        ARK owns the most shares of Crispr Therapeutics AG (CRSP).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis